Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adapt Pharma
Pharma
'Market complexities' help Emergent's Narcan in short term
Despite the launch of generic competition, analysts at Cantor Fitzgerald say the short-term prospects of Emergent's Narcan are still strong.
Kevin Dunleavy
Jan 6, 2022 11:22am
Adapt tests ads encouraging Narcan readiness
Sep 26, 2018 10:16am
Emergent to buy Narcan maker Adapt for $735M
Aug 29, 2018 10:37am
Adapt hires McCann Health Canada for naloxone nasal spray launch
Dec 6, 2016 2:30pm
Senate committee takes Pfizer, Mylan and others to task over naloxone price increases
Jun 7, 2016 12:07pm
